• News
  • Europe

Carlsberg Spinout Traitomic Raises €20 Million Series A

Sofinnova Partners led the round for the Carlsberg spinout.

11/17/2026
•Ali Abounasr El Alaoui
Back to News

Danish biotech Traitomic raised €20 million in a Series A round. Sofinnova Partners led the round. The company develops non-GM plant and microbial traits.


Funding participants

The round marks Traitomic's first external investment since spinning out of Carlsberg. Export and Investment Fund of Denmark, Footprint Firm, Nordic Foodtech VC, PSV Hafnium, and SVG Ventures joined the round. Traitomic holds an exclusive license to use Carlsberg's FIND-IT platform outside brewing.

Customer traction

Traitomic has delivered 116 traits to 47 customers across 32 organisms. Its work spans crop improvement, food production, and industrial biotechnology. Customers are located in Europe, the US, Australia, Southeast Asia, and East Asia.

How FIND-IT works

FIND-IT screens conventional breeding populations for a particular genetic change. It identifies variants already present in conventionally bred plants and microbes, without gene editing. Customers integrate traits into their own elite varieties or production strains.


Traitomic plans to use the funding to expand its business. It will prioritize the US and Australia with local teams and an Australian branch focused on plant trait development. The company is also exploring mushrooms, algae, and probiotic bacteria.